Come up with a name for your new list and we'll add to it:
Antidote Technologies raised a round of funding on October 27, 2011. Investors include
Amadeus Capital Partners.
Antidote, formerly TrialReach, a digital health company that aims to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need them. Antidote …